Literature DB >> 8777974

Pulmonary function abnormalities in type I Gaucher disease.

E Kerem1, D Elstein, A Abrahamov, Y Bar Ziv, I Hadas-Halpern, E Melzer, C Cahan, D Branski, A Zimran.   

Abstract

The purpose of this study was to determine the prevalence of pulmonary function and radiographic abnormalities among patients with type I Gaucher's disease, and to analyse the relationship between the pulmonary involvement and genotype and clinical severity score. All patients attending the Gaucher clinic at the Shaare Zedek Medical Center, Jerusalem, Israel, during the years 1992-1993 were prospectively evaluated. Each patient had pulmonary function tests, chest radiography, clinical assessment in terms of degree of organ involvement, and genotype analysis. Of the 95 patients included in the study (mean +/- SD age 29 +/- 15 yrs), 68% had some pulmonary function abnormalities, most commonly a reduced FRC and transfer coefficient for carbon monoxide (Kco), found in 45% and in 42% of the patients respectively. Total lung capacity (TLC) was reduced in 22% of the patients and forced expiratory flows in approximately one third of the patients. Signs of airtrapping (elevated residual volume (RV) or RV/TLC) were seen in 18% of the patients. Males had a higher incidence of reduced expiratory flow than females, (forced expiratory volume in one second (FEV1) was reduced in 36% of males vs 5% of females). Chest radiographic abnormalities were found in 17% of the patients, although only 4% had severe changes. Patients with abnormal pulmonary function had a significantly higher severity score index than those with normal pulmonary function tests. There was no association between abnormal pulmonary function and genotype or age. In conclusion, abnormal pulmonary function is common among type I Gaucher patients. Pulmonary function tests show airways obstruction, with reduced expiratory flows, reduction in lung volumes and alveolar-capillary diffusion abnormality. The rate of progression and the clinical significance need to be determined.

Entities:  

Mesh:

Year:  1996        PMID: 8777974     DOI: 10.1183/09031936.96.09020340

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  17 in total

Review 1.  Remaining problems in the management of patients with Gaucher disease.

Authors:  A Erikson
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

Review 2.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

3.  Outcome of ten years' echocardiographic follow-up in children with Gaucher disease.

Authors:  Dror Rosengarten; Aya Abrahamov; Amiram Nir; Benjamin Farber; Joram Glaser; Ari Zimran; Deborah Elstein
Journal:  Eur J Pediatr       Date:  2006-08-29       Impact factor: 3.183

Review 4.  Pulmonary Involvement in Niemann-Pick Disease: A State-of-the-Art Review.

Authors:  Felipe Mussi von Ranke; Heloisa Maria Pereira Freitas; Alexandre Dias Mançano; Rosana Souza Rodrigues; Bruno Hochhegger; Dante Escuissato; Cesar Augusto Araujo Neto; Thiago Krieger Bento da Silva; Edson Marchiori
Journal:  Lung       Date:  2016-05-10       Impact factor: 2.584

5.  Fever, pulmonary interstitial fibrosis, and hepatomegaly in a 15-year-old boy with Gaucher disease: a case report.

Authors:  Meng Yang
Journal:  J Med Case Rep       Date:  2018-10-21

6.  Pulmonary hemorrhage in type 3 Gaucher disease: a case report.

Authors:  Ashok Vellodi; Michael Ashworth; Niamh Finnegan; Colin Wallis
Journal:  J Inherit Metab Dis       Date:  2010-08-06       Impact factor: 4.982

Review 7.  Mandibular and dental manifestations of Gaucher disease.

Authors:  H R Saranjam; E Sidransky; W Z Levine; A Zimran; D Elstein
Journal:  Oral Dis       Date:  2012-01-18       Impact factor: 3.511

8.  Echocardiographic Assessment of Left Ventricular Function in Type 1 Gaucher's Disease.

Authors:  Mirta Kozelj; Samo Zver; Vesna Zadnik
Journal:  Adv Hematol       Date:  2010-07-20

9.  Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage.

Authors:  R Y Wang; J T Abe; A H Cohen; W R Wilcox
Journal:  J Inherit Metab Dis       Date:  2008-10-21       Impact factor: 4.982

Review 10.  Gaucher disease: pediatric concerns.

Authors:  Deborah Elstein; Aya Abrahamov; Altoon Dweck; Irith Hadas-Halpern; Ari Zimran
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.